PALATIN TECHNOLOGIES, INC. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31)
PALATIN TECHNOLOGIES, INC. (PTN) reported Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) of $590 for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 · last filed 2018-05-14
- PALATIN TECHNOLOGIES, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $153.00, a 70.29% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $437.00.
- PALATIN TECHNOLOGIES, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $587.00.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 3 month as first filed | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 6 month as first filed | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 9 month as first filed |
|---|---|---|---|---|---|---|
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $153.00 derived: sum of 2 quarters · filed 2018-05-14 | $590.00 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | $153.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | $590.00 10-Q · filed 2018-02-12 | ||||
| 2017-09-30 | $437.00 10-Q · filed 2017-11-13 | |||||
| 2017-03-31 | $587.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $1.10K derived: sum of 2 quarters · filed 2018-05-14 | $525.00 10-Q · filed 2018-05-14 | $0.00 10-Q · filed 2017-05-15 | ||
| 2016-12-31 | $515.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | -$62.00 10-Q · filed 2018-02-12 | $62.00 10-Q · filed 2017-02-10 | |||
| 2016-09-30 | -$577.00 10-Q · filed 2017-11-13 | $577.00 10-Q · filed 2016-11-14 | ||||
| 2016-03-31 | -$6.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $2.57K derived: sum of 2 quarters · filed 2017-05-15 | $2.57K 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | $9.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $9.39K 10-Q · filed 2017-02-10 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | |||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |